Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
First-line chemotherapy standard of care for Hodgkin Lymphoma.
Intermediate and high-risk pediatric and adolescent Hodgkin Lymphoma.
High-risk pediatric Hodgkin Lymphoma (Children's Oncology Group protocol).
Adjuvant and neoadjuvant treatment of early-stage and locally advanced Breast Cancer.
Adjuvant treatment of node-positive or high-risk node-negative Breast Cancer.
Induction therapy for Acute Myeloid Leukemia (AML) in pediatric and adult patients.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
HR-positive, HER2-negative advanced, metastatic, or high-risk early Breast Cancer.
Metastatic Castration-Resistant Prostate Cancer (mCRPC) and High-Risk Castration-Sensitive Prostate Cancer in combination with prednisone.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma, Waldenström's Macroglobulinemia.
Targeted treatment of solid tumors and hematologic malignancies.
